PL2578596T3 - Lewokarymycyna, kompozycje farmaceutyczne, sposoby otrzymywania i jej zastosowania - Google Patents

Lewokarymycyna, kompozycje farmaceutyczne, sposoby otrzymywania i jej zastosowania

Info

Publication number
PL2578596T3
PL2578596T3 PL11786088T PL11786088T PL2578596T3 PL 2578596 T3 PL2578596 T3 PL 2578596T3 PL 11786088 T PL11786088 T PL 11786088T PL 11786088 T PL11786088 T PL 11786088T PL 2578596 T3 PL2578596 T3 PL 2578596T3
Authority
PL
Poland
Prior art keywords
levocarrimycin
pharmaceutical compositions
preparation methods
preparation
methods
Prior art date
Application number
PL11786088T
Other languages
English (en)
Inventor
Yang Jiang
Yuyou Hao
Original Assignee
Shenyang Fuyang Pharmaceutical Technology Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenyang Fuyang Pharmaceutical Technology Co., Ltd. filed Critical Shenyang Fuyang Pharmaceutical Technology Co., Ltd.
Publication of PL2578596T3 publication Critical patent/PL2578596T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL11786088T 2010-05-25 2011-05-25 Lewokarymycyna, kompozycje farmaceutyczne, sposoby otrzymywania i jej zastosowania PL2578596T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010182027 2010-05-25

Publications (1)

Publication Number Publication Date
PL2578596T3 true PL2578596T3 (pl) 2017-09-29

Family

ID=44975203

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11786088T PL2578596T3 (pl) 2010-05-25 2011-05-25 Lewokarymycyna, kompozycje farmaceutyczne, sposoby otrzymywania i jej zastosowania

Country Status (17)

Country Link
US (1) US9089586B2 (pl)
EP (1) EP2578596B1 (pl)
JP (1) JP5866737B2 (pl)
KR (2) KR101625262B1 (pl)
CN (1) CN102247396B (pl)
BR (1) BR112012029905B1 (pl)
CA (1) CA2800019C (pl)
DK (1) DK2578596T3 (pl)
ES (1) ES2633737T3 (pl)
IN (1) IN2012MN02623A (pl)
MX (1) MX346873B (pl)
MY (1) MY164230A (pl)
PH (1) PH12012502329A1 (pl)
PL (1) PL2578596T3 (pl)
RU (1) RU2593499C2 (pl)
WO (1) WO2011147316A1 (pl)
ZA (1) ZA201209739B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX340626B (es) * 2010-05-25 2016-07-18 Shenyang Tonglian Group Co Ltd * Levoisovalerilespiramicina i, ii, iii y preparaciones, métodos de preparación y sus usos.
US9945611B2 (en) 2010-08-04 2018-04-17 Ima Life North America Inc. Bulk freeze drying using spray freezing and agitated drying
DK2601466T3 (en) * 2010-08-04 2018-01-02 Ima Life North America Inc BULK FREEZING DURING USING SPRAY FREEZING AND DRYING UNDER STIRRING
CN103694295B (zh) * 2014-01-08 2016-01-20 华东理工大学 一种优化可利霉素组分的方法
CN105497053B (zh) * 2015-12-31 2018-02-13 沈阳福洋医药科技有限公司 可利霉素在抗结核分枝杆菌感染中的应用
EP3607952B1 (en) * 2017-04-06 2022-07-06 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Use of carrimycin or pharmaceutically acceptable salt thereof for manufacture of medicament for treatment and/or prevention of tumors
AU2018298187A1 (en) * 2017-07-04 2020-02-06 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Use of isovalerylspiramycin I, II and/or III in preparation of drug for treating and/or preventing tumour, and drug
US11413302B2 (en) 2018-01-19 2022-08-16 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Use of carrimycin or active ingredients thereof and use thereof
RU2768583C2 (ru) * 2018-01-19 2022-03-24 Шенянг Фуянг Фармасьютекал Технолоджи Ко., Лтд. Ингибитор мишени рапамицина в клетках млекопитающих, фармацевтическая композиция и их применение
CN110384802B (zh) * 2018-04-17 2021-09-17 沈阳福洋医药科技有限公司 一种用于预防和/或治疗发热的药物、组合产品及其应用
EP3782627A4 (en) * 2018-04-17 2021-07-07 Shanghai Tonglian Pharmaceutical Co., Ltd. MEDICINAL PRODUCT USED TO PREVENT AND / OR TREAT PAIN AND / OR FEVER, A COMBINATION PRODUCT, AND USE OF THEM
CN110384710B (zh) * 2018-04-17 2023-01-10 沈阳福洋医药科技有限公司 一种用于预防和/或治疗疼痛的药物、组合产品及其应用
CN108992416A (zh) * 2018-09-27 2018-12-14 上海同联制药有限公司 一种可利霉素肠溶片及其制备方法
US20220211735A1 (en) * 2019-05-16 2022-07-07 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Medicament and combination product used for preventing, alleviating and/or treating fibrosis, and use thereof
CN112239483B (zh) * 2019-07-18 2023-10-27 沈阳福洋医药科技有限公司 一种化合物及药物组合物
CN111450066B (zh) * 2020-04-24 2022-06-21 沈阳信达泰康医药科技有限公司 一种可利霉素冻干粉针制剂及其制备方法
CN113577087A (zh) * 2020-04-30 2021-11-02 沈阳福洋医药科技有限公司 异戊酰螺旋霉素类化合物或其组合物在制备治疗脓毒症疾病药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5334788A (en) * 1976-09-11 1978-03-31 Sanraku Inc Antibiotics spiramycin derivatives
CN1169947C (zh) * 2002-11-19 2004-10-06 中国医学科学院医药生物技术研究所 必特螺旋霉素的基因工程菌株螺旋霉素链霉菌wsj-195
CN1237976C (zh) * 2003-12-23 2006-01-25 沈阳同联集团有限公司 必特螺旋霉素及其在抗感染性疾病中的应用
MX2007001669A (es) * 2004-08-12 2007-04-10 Glaxosmithkline Zagreb Uso de conjugados especificos celulares para el tratamiento de enfermedades inflamatorias del tracto gastrointestinal.
KR100662363B1 (ko) * 2004-10-19 2007-01-02 엘지전자 주식회사 디스플레이 기기의 인스톨 장치 및 방법
CN101054553A (zh) * 2007-04-09 2007-10-17 中国医学科学院医药生物技术研究所 异戊酰螺旋霉素i基因工程菌株的构建
CN101649325B (zh) * 2009-07-03 2011-09-07 中国医学科学院医药生物技术研究所 一种提高基因工程异戊酰螺旋霉素主组分含量的基因串连技术
MX340626B (es) * 2010-05-25 2016-07-18 Shenyang Tonglian Group Co Ltd * Levoisovalerilespiramicina i, ii, iii y preparaciones, métodos de preparación y sus usos.

Also Published As

Publication number Publication date
KR101706519B1 (ko) 2017-02-14
RU2593499C2 (ru) 2016-08-10
JP2013528167A (ja) 2013-07-08
EP2578596B1 (en) 2017-04-19
EP2578596A4 (en) 2013-11-06
US20130150316A1 (en) 2013-06-13
US9089586B2 (en) 2015-07-28
RU2012156419A (ru) 2014-06-27
MX2012013469A (es) 2013-04-03
CN102247396A (zh) 2011-11-23
MX346873B (es) 2017-03-30
DK2578596T3 (en) 2017-07-17
KR20130020906A (ko) 2013-03-04
MY164230A (en) 2017-11-30
CA2800019C (en) 2015-05-26
KR20160019970A (ko) 2016-02-22
BR112012029905B1 (pt) 2022-01-11
BR112012029905A2 (pt) 2019-08-06
ES2633737T3 (es) 2017-09-25
WO2011147316A1 (zh) 2011-12-01
KR101625262B1 (ko) 2016-05-27
ZA201209739B (en) 2014-03-26
EP2578596A1 (en) 2013-04-10
IN2012MN02623A (pl) 2015-06-12
CA2800019A1 (en) 2011-12-01
JP5866737B2 (ja) 2016-02-17
PH12012502329A1 (en) 2013-02-11
CN102247396B (zh) 2014-05-28

Similar Documents

Publication Publication Date Title
IL253870A0 (en) Certain amino-pyrimidines, their assemblies, and methods of using them
ZA201209739B (en) Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof
PL2562172T3 (pl) Pochodne sfelaktonu, ich kompozycje farmaceutyczne, sposoby wytwarzania i zastosowania
IL222465A0 (en) Certain amino-pyridazines, compositions thereof, and methods for their use
IL225238A0 (en) pharmaceutical preparation
IL225824A0 (en) History of quinoxaline, their preparation and pharmaceutical preparations containing them
EP2447253A4 (en) DIHYDROPYRIMIDIN COMPOUNDS AND MANUFACTURING METHOD, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
IL232577A (en) History of morpholinylbenzotriazine, their preparation and their pharmaceutical preparations
GB201010453D0 (en) Pharmaceutical composition
PL3210990T3 (pl) Lewoizowalerylospiramycyna III i jej preparaty, sposoby wytwarzania i zastosowania
EP2924042A4 (en) BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
PT2504331E (pt) Composto, novas formas desse composto, composições farmacêuticas desse composto e métodos de preparação e utilização
IL228705A (en) Derivatives of Reliable Phenoxy-Ethyl, Pharmaceutical Preparations Containing and Using Them
IL230219A0 (en) History of dihydropyrazole, their preparation and pharmaceutical preparations containing them
EP2766183A4 (en) IRON FIBER COMPOSITION, PREPARATION THEREOF AND USES THEREOF
IL226554A (en) Medicinal preparations containing alisporiovir
IL225823A0 (en) History of quinazoline, their preparation and pharmaceutical preparations containing them
IL221501A (en) Medicinal product containing miramistine
GB201001911D0 (en) Pharmaceutical composition
IL225378A0 (en) History of phenylquinazoline, their preparation and pharmaceutical preparations containing them
EP2565180A4 (en) ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE PRODUCTION METHOD AND PHARMACEUTICAL COMPOSITION THEREWITH
GB0908317D0 (en) Pharmaceutical compounds and compositions
HK1196109A (en) Iron-fiber composition, preparation and uses thereof
PL390620A1 (pl) Preparat farmaceutyczny
AU2011900931A0 (en) Pharmaceutical compositions and use thereof